Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04743791 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT04743791 · ClinicalTrials.gov record · last posted 2026-08-06

Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

Name: Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma — clinical trial record (NCT04743791)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorSally E. Wenzel MD

Started2022-10-17

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

Single center, randomized, placebo- controlled study to assess change in mucociliary clearance of moderate to severe asthma patients after treatment with dupilumab or placebo.

Protocol amendment history 2 changes detected by DataLookout

2026-08-07

Primary completion pushed: 2026-07 → 2027-12

2026-08-07

Completion pushed: 2026-09 → 2028-06

Trial Details

NCT Number	NCT04743791
Lead Sponsor	Sally E. Wenzel MD
Conditions	Asthma
Enrollment	30 participants
Start Date	2022-10-17
Primary Completion	2027-12 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2026-08-06